Formosa Laboratories, Inc. (TPE:4746)
Taiwan
· Delayed Price · Currency is TWD 50.50
-2.20 (-4.17%)
At close: Mar 9, 2026
Formosa Laboratories Revenue
Formosa Laboratories had revenue of 1.16B TWD in the quarter ending September 30, 2025, with 12.59% growth. This brings the company's revenue in the last twelve months to 4.90B, up 6.68% year-over-year. In the year 2024, Formosa Laboratories had annual revenue of 4.73B with 8.50% growth.
Revenue (ttm)
4.90B
Revenue Growth
+6.68%
P/S Ratio
1.24
Revenue / Employee
17.50M
Employees
280
Market Cap
6.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.73B | 370.60M | 8.50% |
| Dec 31, 2023 | 4.36B | 594.94M | 15.80% |
| Dec 31, 2022 | 3.77B | 623.10M | 19.83% |
| Dec 31, 2021 | 3.14B | 66.95M | 2.18% |
| Dec 31, 2020 | 3.08B | 315.87M | 11.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SCI Pharmtech | 1.34B |
| Orient Pharma | 1.28B |
| Orient EuroPharma | 4.53B |
| LIWANLI Innovation | 125.54M |
| Easywell Biomedicals | 588.89M |
| Standard Chemical & Pharmaceutical | 7.02B |
| Merdury Biopharmaceutical | 246.00K |
| Handa Pharmaceuticals | 1.62B |